Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for prevention of cardiovascular events in adults with COVID-19
IRCT20180205038626N7Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of aspirin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Incidence of cardiovascular events. Started Dec 2020; status: completed.
02
Drugs
aspirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20180205038626N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180205038626N7.